Spinal Tech

MicroPort Orthopedics announced that Jimmy Chow, MD, has performed more than 1,000 total hip arthroplasty surgeries using the SuperPath Hip technique.

Two of the week's three worst medical device company stocks are from orthopedic companies — and the experts are advising to sell, according to an Investor Place report.

The global trauma fixation market is expected to grow over the next four years, according to a MicroMarket Monitor report.

Zimmer appointed Michael J. Farrell to its board of directors.

The use of composites in the global orthopedic industry is expected to grow at an average rate of 8.1 percent to reach $596 million by 2020, according to a market report published by ABMRG.

Here are updates from the past week on five orthopedic and spine device company stock reports.

Around 20 years ago, Medicrea launched as an orthopedic device company. In 2006, the company went public and began investing in research and development focusing on new technologies to improve standard spinal products.

The Food and Drug Administration published draft guidance for the minimal manipulation of human cells tissues and cellular and tissue-based products, and now device companies are making comments.

Zyga Technology raised $2 million in an equity-and-options round, hoping to eventually bring in $5 million, according to Mass Device report.

Medtronic, Zimmer or Stryker — who's stock is the best bet?